Home R&D Trials Page 3

Trials

Omecamtiv mecarbil Phase 2 results in chronic heart failure

Alirocumab ODYSSEY trial on alirocumab will continue as planned following interim analysis

Parkinson’s disease: results from a Phase 1 study against alpha-synuclein, safe and well tolerated

Endometriosis: Phase 2B EDELWEISS study on GnRH antagonist

More than 50 percent of eligible Ph+ cml patients maintain treatment-free remission (TFR) after...

Asco 2016: Roche’s latest Tecentriq results underline potential to dominate bladder cancer market

Atopic dermatitis: a positive dupilumab topline results from two phase 3 trials

SOCRATES: Ticagrelor flops in stroke prevention study

Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate

Empagliflozin: new results showing the reduction of cardiovascular events

1234...6Page 3 of 6
© © 2024 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151